Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia

INTRODUCTION: Genomic testing is a relatively new, disruptive and complex health technology with multiple clinical applications in rare diseases, cancer and infection control. Genomic testing is increasingly being implemented into clinical practice, following regulatory approval, funding and adoptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mordaunt, Dylan A, Stark, Zornitza, Santos Gonzalez, Francisco, Dalziel, Kim, Goranitis, Ilias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689401/
https://www.ncbi.nlm.nih.gov/pubmed/38030253
http://dx.doi.org/10.1136/bmjopen-2022-069441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689401/
https://www.ncbi.nlm.nih.gov/pubmed/38030253
http://dx.doi.org/10.1136/bmjopen-2022-069441

Ejemplares similares